BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11881128)

  • 1. Effects of candesartan on cardiac and arterial structure and function in hypertensive subjects.
    Spratt JC; Webb DJ; Shiels A; Williams B
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):227-32. PubMed ID: 11881128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study.
    Cuspidi C; Muiesan ML; Valagussa L; Salvetti M; Di Biagio C; Agabiti-Rosei E; Magnani B; Zanchetti A;
    J Hypertens; 2002 Nov; 20(11):2293-300. PubMed ID: 12409969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-month effects of candesartan cilexetil, an angiotensin II type 1 (AT1) receptor antagonist, on left ventricular mass and hemodynamics in patients with essential hypertension.
    Mitsunami K; Inoue S; Maeda K; Endoh S; Takahashi M; Okada M; Sugihara H; Kinoshita M
    Cardiovasc Drugs Ther; 1998 Oct; 12(5):469-74. PubMed ID: 9926278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals].
    Weisser B; Gerwe M; Braun M; Funken C
    Arzneimittelforschung; 2005; 55(9):505-13. PubMed ID: 16229114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candesartan cilexetil effectively reduces blood pressure in hypertensive children.
    Franks AM; O'Brien CE; Stowe CD; Wells TG; Gardner SF
    Ann Pharmacother; 2008 Oct; 42(10):1388-95. PubMed ID: 18664605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial wave reflection during antihypertensive therapy with barnidipine: a 6-month, open-label study using an integrated cardiovascular ultrasound approach in patients with newly diagnosed hypertension.
    Palombo C; Malshi E; Morizzo C; Rakebrandt F; Corretti V; Santini F; Fraser AG; Kozakova M
    Clin Ther; 2009 Dec; 31(12):2873-85. PubMed ID: 20110026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-response analysis of candesartan-hydrochlorothiazide combination therapy in patients with hypertension.
    Karlson BW; Zetterstrand S; Olofsson B; Elmfeldt D
    Blood Press; 2009; 18(3):149-56. PubMed ID: 19462314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive antihypertensive strategies based on hydrochlorothiazide, candesartan or lisinopril decrease left ventricular mass and improve arterial compliance in patients with type II diabetes mellitus and hypertension.
    Spoelstra-de Man AM; van Ittersum FJ; Schram MT; Kamp O; van Dijk RA; Ijzerman RG; Twisk JW; Brouwer CB; Stehouwer CD
    J Hum Hypertens; 2006 Aug; 20(8):599-611. PubMed ID: 16673014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial.
    Takami T; Saito Y
    Drug Des Devel Ther; 2013; 7():175-83. PubMed ID: 23662047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candesartan cilexetil improves left ventricular function, left ventricular hypertrophy, and endothelial function in patients with hypertensive heart disease.
    Isobe N; Taniguchi K; Oshima S; Ono Z; Adachi H; Toyama T; Naito S; Hoshizaki H; Kamiyama H
    Circ J; 2002 Nov; 66(11):993-9. PubMed ID: 12419928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Office and ambulatory blood pressure control with a fixed-dose combination of candesartan and hydrochlorothiazide in previously uncontrolled hypertensive patients: results of CHILI CU Soon.
    Mengden T; Hübner R; Bramlage P
    Vasc Health Risk Manag; 2011; 7():761-9. PubMed ID: 22241950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy between hydrochlorothiazide and chlorthalidone on central aortic pressure when added on to candesartan in treatment-naïve patients of hypertension.
    Kwon BJ; Jang SW; Choi KY; Kim DB; Cho EJ; Ihm SH; Youn HJ; Kim JH
    Hypertens Res; 2013 Jan; 36(1):79-84. PubMed ID: 23034468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of Central Blood Pressure to Hypertensive Target Organ Damages During Antihypertensive Treatment: The J-TOP Study.
    Shimizu M; Hoshide S; Ishikawa J; Yano Y; Eguchi K; Kario K
    Am J Hypertens; 2015 Aug; 28(8):980-6. PubMed ID: 25548141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled comparison of the efficacy and tolerability of candesartan cilexetil, 8 mg, and losartan, 50 mg, as monotherapy in patients with essential hypertension, using 36-h ambulatory blood pressure monitoring.
    Baguet JP; Nisse-Durgeat S; Mouret S; Asmar R; Mallion JM
    Int J Clin Pract; 2006 Apr; 60(4):391-8. PubMed ID: 16620350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlations between blood pressure, left ventricular hypertrophy, and left ventricular diastolic function in hypertensive patients].
    Ito O; Okamoto M; Murakami Y; Nakayama R
    J Cardiol; 1991; 21(4):931-41. PubMed ID: 1844449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of aliskiren 300  mg/hydrochlorothiazide 25  mg (± amlodipine 5  mg) in hypertensive patients not controlled by candesartan 32  mg plus HCT 25  mg.
    Schweizer J; Ulmer HJ; Benduhn H; Klebs S
    Curr Med Res Opin; 2011 Jan; 27(1):131-40. PubMed ID: 21117946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indapamide SR versus candesartan and amlodipine in hypertension: the X-CELLENT Study.
    London G; Schmieder R; Calvo C; Asmar R
    Am J Hypertens; 2006 Jan; 19(1):113-21. PubMed ID: 16461202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of candesartan cilexetil with hydrochlorothiazide on blood pressure and ST-segment depression in patients with arterial hypertension].
    Uen S; Un I; Fimmers R; Vetter H; Mengden T
    Dtsch Med Wochenschr; 2007 Jan; 132(3):81-6. PubMed ID: 17219340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.